Airway Intervention Registry (AIR) extension: Recurrent Respiratory Papillomatosis
Not Applicable
Completed
- Conditions
- Recurrent Respiratory PapillomatosisRespiratoryOther diseases of upper respiratory tract
- Registration Number
- ISRCTN36100560
- Brief Summary
2023 Other publications in https://doi.org/10.3310/nihropenres.13244.2 Our experience in developing and operating the Airway Intervention Registry for Recurrent Respiratory Papillomatosis (AIR-RRP): national data collection (added 19/07/2024)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
All patients (adults and paediatrics) with a diagnosis of RRP receiving at least one intervention for RRP in a UK NHS hospital
Exclusion Criteria
Patient/parent/guardian unable/unwilling to provide written informed assent/consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Effectiveness of the interventions, assessed using the Derkay staging system to quantify RRP severity based on involvement of laryngeal structures. As this is observational data, the study will not require the patients to attend additional hospital appointments. They will be assessed at their routine hospital visits which will be scheduled according to clinical need over the course of the 28-month data collection period.<br>2. Quality of life, measured using the Voice Handicap Index (VHI) questionnaire (for patients aged 16 or over) or the paediatric Voice Handicap Index (pVHI) for patients under 16. Patients currently complete these questionnaires as part of their standard care at hospital appointments. Patients who have consented to taking part in the study will also be given a unique QoL ID so that they can submit additional QoL forms via a secure patient website at their convenience.
- Secondary Outcome Measures
Name Time Method